Hamzic, Seid; Amstutz, Ursula; Largiadèr, Carlo Rodolfo (2018). Come a long way, still a ways to go: from predicting and preventing fluoropyrimidine toxicity to increased efficacy? Pharmacogenomics, 19(8), pp. 689-692. Future Medicine 10.2217/pgs-2018-0040
![[img]](https://boris.unibe.ch/style/images/fileicons/text.png) |
Text
pgs-2018-0040.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (330kB) |
Item Type: |
Journal Article (Further Contribution) |
|---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Institute of Clinical Chemistry |
UniBE Contributor: |
Hamzic, Seid, Amstutz, Ursula, Largiadèr, Carlo Rodolfo |
Subjects: |
600 Technology > 610 Medicine & health |
ISSN: |
1462-2416 |
Publisher: |
Future Medicine |
Language: |
English |
Submitter: |
Marie-Christine Müller |
Date Deposited: |
03 Apr 2019 12:37 |
Last Modified: |
05 Dec 2022 15:26 |
Publisher DOI: |
10.2217/pgs-2018-0040 |
PubMed ID: |
29783877 |
Uncontrolled Keywords: |
5-FU BSA-based dosing DPYD TDM capecitabine pharmacogenetics |
BORIS DOI: |
10.7892/boris.125805 |
URI: |
https://boris.unibe.ch/id/eprint/125805 |
Actions (login required)
 |
Edit item |